TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34714539

Group type: EXPERIMENTAL
Intervention: Group II (0.3 mL/kg of 0.25 percent bupivacaine, fentanyl 50 µg, and naloxone 100 ng)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Group I (0.3 mL/kg of 0.25 percent bupivacaine)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Group III (0.3 mL/kg of 0.25 percent bupivacaine and fentanyl 50 µg)
Number of subjects: 135
Study: 36175722

Group type: EXPERIMENTAL
Intervention: Biologic therapy prior to surgery
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no biologic therapy)
Number of subjects: 65
Study: 35170726

Group type: EXPERIMENTAL
Intervention: Radiofrequency-assisted liposuction (RFAL; Group A)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Renuvion helium subdermal coagulation (Group B)
Number of subjects: 176

Group type: COMPARATOR
Intervention: VASER-assisted liposuction (VAL) alone (Group C)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Overall satisfaction as assessed by an independent plastic surgeon
Number of subjects: 176
Study: 32282787

Group type: EXPERIMENTAL
Intervention: Novel bone conduction hearing aid system
Number of subjects: 12

Group type: COMPARATOR
Intervention: BCHA headband system
Number of subjects: 12
Study: 36192602

Group type: EXPERIMENTAL
Intervention: Attention training intervention (five sessions, online)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Practice group (repeatedly performed the same vWM task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive group (test-retest effects)
Number of subjects: 0
Study: 34137476

Group type: EXPERIMENTAL
Intervention: Dipyridamole (up to 300 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 32498637

Group type: EXPERIMENTAL
Intervention: Exergaming training program (Xbox 360 Kinect™; 20 sessions, 2-3 times per week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (volunteers without a cancer diagnosis; n=15)
Number of subjects: 45
Study: 33856638

Group type: EXPERIMENTAL
Intervention: pembrolizumab plus pomalidomide and dexamethasone (n = 15)
Number of subjects: 27

Group type: COMPARATOR
Intervention: pomalidomide and dexamethasone alone (n = 12)
Number of subjects: 27
Study: 32940419

Group type: EXPERIMENTAL
Intervention: HIRREM (linked to brainwaves)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Random tones (sham control)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both HIRREM and Random tones
Number of subjects: 107
Study: 34186201

Group type: EXPERIMENTAL
Intervention: Habitual chewing on the affected side
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Condylar path angle on the affected side
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lateral guidance angles on the affected side
Number of subjects: 24
Study: 32388857

Group type: EXPERIMENTAL
Intervention: Audio-visual module
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional instructional module
Number of subjects: 32
Study: 36244879

Group type: EXPERIMENTAL
Intervention: High-dose influenza vaccine (HD)
Number of subjects: 823

Group type: COMPARATOR
Intervention: Standard-dose influenza vaccine (SD)
Number of subjects: 823
Study: 33769732

Group type: COMPARATOR
Intervention: Methotrexate (0.3 mg/kg/week)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Combination of Methotrexate (0.15 mg/kg/week) and Cyclosporine (2.5 mg/kg/day)
Number of subjects: 133
Study: 33944974

Group type: EXPERIMENTAL
Intervention: WhatsApp reminders (W)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Email reminders (E)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 54
Study: 32319791

Group type: EXPERIMENTAL
Intervention: Automated Insulin Delivery (AID)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional Therapy
Number of subjects: 10
Study: 33742652

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Overall Cohort (Tofacitinib 5 mg or 10 mg BID)
Number of subjects: 1124
Study: 34726472

Group type: EXPERIMENTAL
Intervention: Clinical Pilates (CLP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional physiotherapy (COP)
Number of subjects: 40
Study: 34715718

Group type: EXPERIMENTAL
Intervention: Phosphorus 30cH
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Bryonia alba 30cH
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Gelsemium sempervirens 30cH
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20000
Study: 34450326

Group type: EXPERIMENTAL
Intervention: Generalized estimating equation (GEE) approach for sample size estimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Closed-form sample size and power formulas for LCRTs and CCRTs
Number of subjects: 0
Study: 35834624

Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation (nitrate-rich beetroot juice)
Number of subjects: 26
Study: 33099307

Group type: EXPERIMENTAL
Intervention: Female GPs
Number of subjects: 3755

Group type: EXPERIMENTAL
Intervention: Practices in more deprived areas
Number of subjects: 3755

Group type: EXPERIMENTAL
Intervention: Main urban centre practices
Number of subjects: 3755
Study: 34196141

Group type: EXPERIMENTAL
Intervention: Spironolactone (part of a placebo-controlled randomized clinical trial)
Number of subjects: 67
Study: 35568602

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) supplemented by usual care (2 in-person and 4 follow-up phone calls with a nurse educator)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) supplemented by usual care
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (every 3 months visit with pediatric endocrinologist)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study: 32711528

Group type: EXPERIMENTAL
Intervention: InConnection approach
Number of subjects: 300

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 300
Study: 36112172

Group type: COMPARATOR
Intervention: Non-spatial secondary task (arithmetic)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control condition (no secondary task)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Visuospatial secondary task (star movement)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Delay duration (20 s, 60 s)
Number of subjects: 87
Study: 32029126

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 1023
Study: 35451096

Group type: EXPERIMENTAL
Intervention: Supine assessment of orthostatic hypotension (OH)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Seated assessment of orthostatic hypotension (OH)
Number of subjects: 534
Study: 32289841

Group type: EXPERIMENTAL
Intervention: Body weight load
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Lean body mass load
Number of subjects: 31
Study: 34756489

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) on flexor carpi ulnaris (FCU)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) on extensor carpi radialis brevis and longus (ECRB/L)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo taping (PT) on flexor carpi ulnaris (FCU)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo taping (PT) on extensor carpi radialis brevis and longus (ECRB/L)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 72
Study: 33605765

Group type: EXPERIMENTAL
Intervention: Ancilla-free experimental scheme for the measurement of many-body Chern number (MBCN) using statistical correlations of randomized measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical correlations of randomized measurements
Number of subjects: 0
Study: 35807160

Group type: EXPERIMENTAL
Intervention: Topical 0.1% fluorometholone combined with 0.05% azelastine
Number of subjects: 111

Group type: COMPARATOR
Intervention: Topical 0.1% fluorometholone alone
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Both groups (combination and isolated fluorometholone)
Number of subjects: 111
Study: 33127993

Group type: EXPERIMENTAL
Intervention: Lithium administration
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 34781788

Group type: EXPERIMENTAL
Intervention: Alcoholic drinks targeting a BAC of 0.05%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo drinks
Number of subjects: 60
Study: 33774558

Group type: EXPERIMENTAL
Intervention: Internet-delivered exposure therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Internet-delivered cognitive behavioral therapy (iCBT)
Number of subjects: 69
Study: 35218019

Group type: EXPERIMENTAL
Intervention: Targeted temperature treatment (TTM) at 33°C for 24 or 48 hours
Number of subjects: 310
Study: 32039840

Group type: EXPERIMENTAL
Intervention: 12-week exercise training
Number of subjects: 101
Study: 34988932

Group type: EXPERIMENTAL
Intervention: NeuroMuscular Taping (NMT) applied over 8 days following back-school therapy (BST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Back-school therapy (BST) alone
Number of subjects: 0
Study: 34472906

Group type: EXPERIMENTAL
Intervention: Socially inactive lifestyle
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Slightly unhealthy lifestyle
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Highly physically active lifestyle
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Health-promoting lifestyle
Number of subjects: 589
Study: 34507361

Group type: EXPERIMENTAL
Intervention: Gonyautoxin 2/3 (GTX 2/3) 40 ?g in 30 mL sodium chloride 0.9%
Number of subjects: 48

Group type: COMPARATOR
Intervention: Levobupivacaine (300 mg), ketorolac (60 mg), and epinephrine (1 mg) in 150 mL sodium chloride 0.9%
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gonyautoxin 2/3 (GTX 2/3)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Levobupivacaine, ketorolac, and epinephrine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 34329947

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 151
Study: 34263416

Group type: EXPERIMENTAL
Intervention: SRP + Er,Cr:YSGG laser
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: SRP + diode laser
Number of subjects: 26

Group type: COMPARATOR
Intervention: SRP-only
Number of subjects: 26
Study: 34213641

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Nomogram based on multivariable model including age, pre-operative hemoglobin count, and pre-operative albumin count
Number of subjects: 233
Study: 32199540

Group type: EXPERIMENTAL
Intervention: Recovery Support Navigators (RSN)
Number of subjects: 4236

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 4236
Study: 35606826

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied to the left dorsolateral prefrontal cortex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 34615782

Group type: EXPERIMENTAL
Intervention: Avalon Avohex
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Listerine Miswak
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Optima Aloe Dent Mouthrinse
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no mouthrinse)
Number of subjects: 52
Study: 32369989

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra virgin olive oil and nuts
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Hypocaloric Mediterranean diet and intensive lifestyle program
Number of subjects: 67
Study: 35968286

Group type: EXPERIMENTAL
Intervention: 2 Hz EA group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 100 Hz EA group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 2/100 Hz EA group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (Mecobalamin tablets)
Number of subjects: 160
Study: 32376754

Group type: EXPERIMENTAL
Intervention: Ischaemia-free liver transplantation (IFLT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional liver transplantation (CLT)
Number of subjects: 68
Study: 35461026

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Intravenous dexketoprofen
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen
Number of subjects: 210
Study: 34496751

Group type: EXPERIMENTAL
Intervention: Education based on Acceptance and Commitment Therapy (ACT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 6
Study: 32747146

Group type: EXPERIMENTAL
Intervention: Orthognathic surgery
Number of subjects: 267

Group type: COMPARATOR
Intervention: Nonsurgical controls
Number of subjects: 267
Study: 35233984

Group type: EXPERIMENTAL
Intervention: Goserelin (Z), 3.6 mg, n = 8
Number of subjects: 16
Study: 33176437

Group type: EXPERIMENTAL
Intervention: Omecamtiv Mecarbil (OM) 25 mg BID
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Omecamtiv Mecarbil (OM) pharmacokinetically guided dose titration (OM-PK)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study: 33307907

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) consisting of 4 cycles of 5-min ischemia at 200 mmHg followed by 5-min reperfusion.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham-RIPC (control group).
Number of subjects: 58

Group type: COMPARATOR
Intervention: Remote ischemic preconditioning (RIPC) and Sham-RIPC (control group).
Number of subjects: 58
Study: 34662449

Group type: EXPERIMENTAL
Intervention: Cirrhosis regression observed in 16% (176/1,135) between baseline and week 48 (W48)
Number of subjects: 1135

Group type: COMPARATOR
Intervention: Nonregression of cirrhosis
Number of subjects: 1135
Study: 34606293

Group type: EXPERIMENTAL
Intervention: Oral hygiene system (test group) involving a novel smart‐connected Oral‐B® iO oscillating‐rotating electric toothbrush, 0.454 percent stabilized stannous fluoride dentifrice, 0.07 percent cetylpyridinium chloride rinse, and floss
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control regimen involving a manual toothbrush and 0.243 percent sodium fluoride dentifrice
Number of subjects: 0
Study: 32806525

Group type: EXPERIMENTAL
Intervention: Face-to-face exercise performed by an instructor (Group L)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Exercise using machines (Group P)
Number of subjects: 117
Study: 34931313

Group type: EXPERIMENTAL
Intervention: Internet-based CBT
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 35200634

Group type: EXPERIMENTAL
Intervention: Dunaliella salina extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34246458

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study: 71031583

Group type: EXPERIMENTAL
Intervention: Prophylaxis
Number of subjects: 607

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Non-Escherichia coli infections
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Escherichia coli infections
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Bowel and bladder dysfunction (BBD) assessment
Number of subjects: 607
Study: 35373021

Group type: EXPERIMENTAL
Intervention: OkKidney app
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard of care (multidisciplinary renal team)
Number of subjects: 80
Study: 32206812

Group type: EXPERIMENTAL
Intervention: Collaborative early childhood intervention (ECI) services based on the International Classification of Functioning, Disability and Health framework and family‐centered approaches.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Regular home visits by local social workers (Control).
Number of subjects: 24
Study: 33715648

Group type: EXPERIMENTAL
Intervention: Spirulina supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34282647

Group type: EXPERIMENTAL
Intervention: 3-minute dilute povidone-iodine soak and scrub followed by standard 2-step skin preparation (alcohol scrub and chlorhexidine/alcohol paint)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard 2-step skin antiseptic preparation (alcohol scrub followed by chlorhexidine/alcohol paint)
Number of subjects: 242
Study: 32985369

Group type: EXPERIMENTAL
Intervention: IV administration of 15 mg/kg TXA
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 174
Study: 35044035

Group type: EXPERIMENTAL
Intervention: Transurethral cystolithotripsy (TUCL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Percutaneous cystolithotripsy (PCCL)
Number of subjects: 100
Study: 33386426

Group type: EXPERIMENTAL
Intervention: Hip arthroscopic osteochondroplasty
Number of subjects: 108
Study: 35060544

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 34000245

Group type: EXPERIMENTAL
Intervention: Radiotherapy with concurrent temozolomide (75 mg/m2 per day)
Number of subjects: 751

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Radiotherapy with adjuvant temozolomide (12 4-week cycles of 150-200 mg/m2 on days 1-5)
Number of subjects: 751

Group type: COMPARATOR
Intervention: Radiotherapy without adjuvant temozolomide
Number of subjects: 751
Study: 34475187

Group type: EXPERIMENTAL
Intervention: Acquire 22G TBNB needles
Number of subjects: 158

Group type: COMPARATOR
Intervention: Standard 22G TBNA needles
Number of subjects: 158
Study: 32208125

Group type: EXPERIMENTAL
Intervention: 100mg melatonin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33567888

Group type: EXPERIMENTAL
Intervention: Structured yoga program for 12 weeks
Number of subjects: 113

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 113
Study: 32348280

Group type: COMPARATOR
Intervention: Control (pedometer only)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: App (pedometer synced to personal smartphone)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: App-coach (pedometer synced to personal smartphone + health coach)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 36085679

Group type: EXPERIMENTAL
Intervention: EEG neurofeedback (NFB) training for 12 weeks (24 sessions) targeting frontal gamma activity.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: EEG neurofeedback (NFB) training using a brain-computer interface (BCI) delivering F3-F4 gamma coherence NFB.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo neurofeedback (NFB) training.
Number of subjects: 31
Study: 34547013

Group type: EXPERIMENTAL
Intervention: Myhixel I© device with Sphincter Control Training (SCT) program for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: No device with Sphincter Control Training (SCT) program for 8 weeks
Number of subjects: 40
Study: 36274214

Group type: EXPERIMENTAL
Intervention: etoposide-platinum-atezolizumab
Number of subjects: 41
Study: 35584872

Group type: EXPERIMENTAL
Intervention: Oral semaglutide for 24 weeks
Number of subjects: 172

Group type: COMPARATOR
Intervention: DPP-4 inhibitor
Number of subjects: 172
Study: 33245161

Group type: EXPERIMENTAL
Intervention: Compassion training
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 57

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 57
Study: 33060078

Group type: EXPERIMENTAL
Intervention: Stand-alone VR (6-week internet-based intervention with weekly online sessions and daily exercises)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Blended VR (stand-alone VR supplemented with face-to-face physiotherapy support)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 322
Study: 35383253

Group type: EXPERIMENTAL
Intervention: Solacea 19H dialyzer with 1/4th of the regular anticoagulation dose
Number of subjects: 10

Group type: COMPARATOR
Intervention: FX800 CorDiax dialyzer
Number of subjects: 10
Study: 33148184

Group type: EXPERIMENTAL
Intervention: Community recruitment strategies
Number of subjects: 234
Study: 34271175

Group type: EXPERIMENTAL
Intervention: CKD-Clinical Decision Support (CKD-CDS) intervention
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 7000
Study: 33016688

Group type: COMPARATOR
Intervention: Smoking individuals (both men and women)
Number of subjects: 2413

Group type: COMPARATOR
Intervention: Male smoking population
Number of subjects: 2413

Group type: EXPERIMENTAL
Intervention: Income level
Number of subjects: 2413

Group type: EXPERIMENTAL
Intervention: Single women and men
Number of subjects: 2413

Group type: EXPERIMENTAL
Intervention: Individuals from small towns (less than 50,000 inhabitants)
Number of subjects: 2413
Study: 34030944

Group type: EXPERIMENTAL
Intervention: Longer-stay group (n = 150)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Shorter-stay group (n = 80)
Number of subjects: 230
Study: 34471722

Group type: EXPERIMENTAL
Intervention: d-alpha tocopheryl acetate products
Number of subjects: 15

Group type: COMPARATOR
Intervention: octyl palmitate (positive control)
Number of subjects: 15

Group type: COMPARATOR
Intervention: negative control (no test material)
Number of subjects: 15
Study: 34213007

Group type: EXPERIMENTAL
Intervention: Anderson-Rubin test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kleibergen test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditional likelihood ratio test
Number of subjects: 0